Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要